CNBT
VRTX icon

Canandaigua National Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Canandaigua National Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
+427
New +$189K 0.02% 300
2025
Q2 		– Sell
-452
Closed -$219K – 318
2025
Q1 		$219K Buy
+452
New +$211K 0.02% 294

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Canandaigua National Bank & Trust's VRTX Position: Q2 2026 in Review

Canandaigua National Bank & Trust opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 427 shares worth $212K. The stake represents 0.02% of the portfolio and ranks #300 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in VRTX as recently as Q1 2025.

Canandaigua National Bank & Trust first reported a position in VRTX in Q1 2025 and has held it in 2 quarters since. The position peaked at $219K in Q1 2025. 737 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Canandaigua National Bank & Trust held 427 shares of Vertex Pharmaceuticals worth $212K as of Q2 2026.
  • Vertex Pharmaceuticals was a new Canandaigua National Bank & Trust position in Q2 2026.
  • Vertex Pharmaceuticals made up 0.02% of Canandaigua National Bank & Trust's portfolio in Q2 2026, its #300 holding.
  • Canandaigua National Bank & Trust first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • Canandaigua National Bank & Trust's Vertex Pharmaceuticals position peaked at $219K in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Canandaigua National Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.